- Home
- RAPT vs STIM Comparison
RAPT vs STIM Comparison
Compare RAPT & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- STIM
- Stock Information
- Founded
- RAPT 2015
- STIM 2003
- Country
- RAPT United States
- STIM United States
- Employees
- RAPT N/A
- STIM N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- STIM Medical/Dental Instruments
- Sector
- RAPT Health Care
- STIM Health Care
- Exchange
- RAPT Nasdaq
- STIM Nasdaq
- Market Cap
- RAPT 194.2M
- STIM 224.8M
- IPO Year
- RAPT 2019
- STIM 2018
- Fundamental
- Price
- RAPT $13.18
- STIM $3.61
- Analyst Decision
- RAPT Buy
- STIM Strong Buy
- Analyst Count
- RAPT 5
- STIM 2
- Target Price
- RAPT $33.60
- STIM $7.00
- AVG Volume (30 Days)
- RAPT 117.5K
- STIM 1.5M
- Earning Date
- RAPT 08-07-2025
- STIM 08-05-2025
- Dividend Yield
- RAPT N/A
- STIM N/A
- EPS Growth
- RAPT N/A
- STIM N/A
- EPS
- RAPT N/A
- STIM N/A
- Revenue
- RAPT N/A
- STIM $111,106,000.00
- Revenue This Year
- RAPT N/A
- STIM $105.70
- Revenue Next Year
- RAPT N/A
- STIM $11.77
- P/E Ratio
- RAPT N/A
- STIM N/A
- Revenue Growth
- RAPT N/A
- STIM 54.17
- 52 Week Low
- RAPT $5.67
- STIM $0.52
- 52 Week High
- RAPT $26.56
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- RAPT 63.64
- STIM 51.83
- Support Level
- RAPT $11.19
- STIM $3.00
- Resistance Level
- RAPT $13.66
- STIM $3.43
- Average True Range (ATR)
- RAPT 0.75
- STIM 0.25
- MACD
- RAPT 0.19
- STIM 0.03
- Stochastic Oscillator
- RAPT 86.53
- STIM 87.72
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.